Why Charles River (CRL) International Revenue Trends Deserve Your Attention

Core Insights - Charles River Laboratories (CRL) reported total revenue of $1.03 billion for the quarter ending June 2024, a decrease of 3.2% year-over-year [4] - The company's international revenue performance is crucial for understanding its financial resilience and growth prospects [1][2] International Revenue Analysis - Asia Pacific contributed $50.39 million, accounting for 4.9% of total revenue, with a surprise decline of -10.07% compared to expectations of $56.03 million [5] - Europe generated $271.38 million, making up 26.5% of total revenue, with a surprise of -4.12% against the projected $283.04 million [6] - Canada reported $125.24 million in revenue, representing 12.2% of total revenue, exceeding expectations by +19.89% [7] - Other International markets, including Brazil and Israel, contributed $7.68 million, accounting for 0.8% of total revenue, with a significant surprise of +220.08% [8] Future Projections - Analysts project total revenue of $1.04 billion for the current fiscal quarter, reflecting a 1.6% increase year-over-year, with expected contributions from Asia Pacific (5%), Europe (27.2%), Canada (11.1%), and Other International (0.3%) [9] - For the full year, total revenue is anticipated to be $4.11 billion, a decrease of 0.5% compared to last year, with specific contributions from Asia Pacific (5.2%), Europe (27.7%), Canada (11%), and Other International (0.7%) [10] Conclusion - The reliance on international markets presents both opportunities and challenges for Charles River, making the tracking of international revenue trends essential for future projections [11]